Concord Medical(US:CCM) Prnewswireยท2025-01-06 12:30Core Viewpoint - Concord Medical Services Holdings Limited, a healthcare provider specializing in cancer treatment, announced the adoption of the Fifth Amended and Restated Memorandum and Articles of Association during its 2024 annual general meeting of shareholders held on December 27, 2024 [1]. Group 1: Company Overview - Concord Medical provides a full cycle of premium oncology services, including cancer diagnosis, treatment, education, and prevention [2]. - The company focuses on multidisciplinary cancer care and operates cancer hospitals equipped with advanced technology, such as a state-of-the-art proton therapy system [2]. - Concord Medical aims to enhance the quality and accessibility of cancer care through its network of self-owned hospitals and partnered facilities across China [2].